Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression
Open Access
- 1 November 2010
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 23 (11), 1518-1523
- https://doi.org/10.1038/modpathol.2010.131
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Additional Genetic High-Risk Features Such As 11q Deletion, 17p Deletion, and V3-21 Usage Characterize Discordance of ZAP-70 and VH Mutation Status in Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2006
- The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemiaBlood, 2005
- ZAP-70 Expression in B-Cell Hematologic Malignancy Is Not Limited to CLL/SLLAmerican Journal of Clinical Pathology, 2004
- ZAP-70 Expression in B-Cell Hematologic Malignancy Is Not Limited to CLL/SLLAmerican Journal of Clinical Pathology, 2004
- High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemiaBlood, 2003
- Unexpected Requirement for ZAP-70 in Pre-B Cell Development and Allelic ExclusionImmunity, 2003
- ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileBlood, 2003
- Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemiaBlood, 2002
- Chronic lymphocytic leukemiaCurrent Opinion in Hematology, 2000
- Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.JCI Insight, 1998